- J&J doubles down on neurological drugs with $14.6 billion intracellular deal Reuters
- J&J closes $14.6 billion deal for intracellular therapies Axios
- J&J deepens neuropsychology with $14.6 billion acquisition Investor Business Daily
- J&J buys psychiatric drug developer Intra-Cellular for $14.6 billion BioPharma Diving
- Johnson & Johnson in talks to acquire intracellular therapies Yahoo Finance
